Primary hyperparathyroidism is a condition in which one or more of the four parathyroid glands produce too much parathyroid hormone, driving blood calcium levels above normal. It is the most common cause of high calcium found on routine blood tests, and its clinical presentation has shifted dramatically over the past few decades, from a disease marked by severe bone loss and kidney stones to one often caught early with mild or even no obvious symptoms. That quieter presentation can be misleading, though, because the excess hormone still takes a toll on bones, kidneys, the cardiovascular system, and even cognition.
How the Parathyroid Glands Lose Their Balance
Your parathyroid glands are four tiny structures, each roughly the size of a grain of rice, sitting behind the thyroid in your neck. Their sole job is regulating calcium in the blood. They do this through a sensor on their surface called the calcium-sensing receptor, which detects moment-to-moment shifts in blood calcium and adjusts parathyroid hormone output accordingly.1PubMed. Role of the calcium-sensing receptor in parathyroid gland physiology When calcium dips, more hormone is released; when calcium rises, the glands quiet down. In primary hyperparathyroidism, that feedback loop breaks. The gland or glands keep pumping out hormone even though calcium is already elevated, and the body responds by pulling even more calcium from bones, reabsorbing more from the kidneys, and absorbing more from food.
What Causes It
In roughly 80 to 85 percent of cases, a single benign tumor called a parathyroid adenoma is responsible. These adenomas are typically tiny, weighing less than a gram. In about 10 to 15 percent of patients, more than one gland is overactive, a situation called multigland hyperplasia. Parathyroid carcinoma accounts for less than 1 percent of cases.2ScienceDirect / Journal of Clinical and Translational Endocrinology: Case Reports. Extreme hypercalcemia due to a giant parathyroid adenoma This distribution matters for treatment because a single adenoma can often be removed through a focused, minimally invasive surgery, while multigland disease typically requires a more extensive operation.
The Shift From Severe to Silent
A generation ago, most people with primary hyperparathyroidism showed up with obvious bone disease or kidney stones. That changed once automated blood chemistry panels became routine. A large review spanning 25 years found that once accurate serum calcium testing became widespread, kidney stones and overt bone disease were present in fewer than 5 percent of newly diagnosed cases, and roughly half of patients had few or no symptoms at all.3PubMed. Clinical spectrum of primary hyperparathyroidism: evolution with changes in medical practice and technology The disease itself did not become milder; doctors simply started catching it earlier, before the calcium had time to do serious damage. That is both good news and a source of confusion, because “asymptomatic” does not mean harmless.
Kidney Stones and Declining Kidney Function
Kidney complications remain one of the hallmark concerns. Excess parathyroid hormone leads to more calcium in the urine, which encourages stone formation and calcium deposits in kidney tissue, a condition called nephrocalcinosis. Even among patients classified as asymptomatic, kidney stones show up on imaging about 7 percent of the time, well above the roughly 1.6 percent rate in the general population.4The Journal of Clinical Endocrinology & Metabolism. Nephrolithiasis and Renal Calcifications in Primary Hyperparathyroidism People who develop stones tend to be younger and more often male.
Surgery helps. Shortly after a successful parathyroidectomy, the risk of new stone episodes drops to the baseline rate seen in people with ordinary, non-hormonal stone disease. Nephrocalcinosis is also largely reversible after surgery. However, some residual risk persists, and studies have shown that former patients still have higher urinary calcium excretion and lower serum phosphate levels compared with healthy controls, suggesting a lingering mineral imbalance even after cure.5The Journal of Clinical Endocrinology & Metabolism. Nephrolithiasis and Renal Calcifications in Primary Hyperparathyroidism Declining kidney function overall is also associated with primary hyperparathyroidism and is one of the criteria that can tip the balance toward recommending surgery.6PubMed Central. Renal manifestations of primary hyperparathyroidism
Brain Fog, Fatigue, and Mood Changes
One of the most frustrating aspects of primary hyperparathyroidism is how it affects the mind. About a quarter of patients experience neuropsychiatric symptoms, which can include depression, anxiety, fatigue, and difficulty concentrating.7PubMed Central. Neuropsychiatric manifestations of primary hyperparathyroidism These are vague enough that they often get chalked up to stress, aging, or other conditions before the real cause is identified. In rarer cases, the picture can escalate to mania, delirium, or psychosis.
Objective testing backs up what patients report. One study using standardized neurocognitive testing found that about 44 percent of patients had measurable cognitive dysfunction before surgery compared with the general population. After parathyroidectomy, that figure dropped to 22 percent, with executive function showing the clearest gains.8PubMed. Objectively measured cognitive dysfunction in patients with primary hyperparathyroidism improves after parathyroidectomy These improvements held for both men and women. The evidence increasingly shows that parathyroidectomy brings persistent relief from depression, anxiety, and fatigue as well, though individual responses vary.9PubMed Central. Neuropsychiatric manifestations of primary hyperparathyroidism
Cardiovascular Risks
High parathyroid hormone levels are not kind to the heart and blood vessels. Patients with parathyroid gland disorders have higher rates of hypertension, abnormal heart rhythms, thickening of the heart’s main pumping chamber, heart failure, and calcium buildup in blood vessels, all of which translate into higher cardiac-related illness and death.10PubMed Central. The Parathyroid Gland and Heart Disease. Research in treatment-naive patients has shown that parathyroid hormone levels independently correlate with higher nighttime blood pressure, stiffer arteries, and increased heart muscle mass, suggesting the hormone itself promotes remodeling of both the heart and the blood vessel walls.11PubMed Central. Plasma parathyroid hormone and cardiovascular disease in treatment-naive patients with primary hyperparathyroidism: The EPATH trial Whether surgery fully reverses these cardiovascular changes is still debated, but preventing further damage is one more reason the condition should not be dismissed as benign.
Bone Strength Beyond Bone Density
Chronic excess parathyroid hormone pulls calcium from the skeleton, and bone mineral density often declines, particularly at sites rich in cortical bone like the forearm. But bone density alone does not tell the full story. Bone strength depends on size, internal architecture, and how the disease has evolved over time, not just how dense the bone appears on a scan.12Springer Link (Osteoporosis International). Bone strength in primary hyperparathyroidism This is why some patients fracture at bone density levels that would not raise alarms in someone without the condition, while others with clearly low readings manage to avoid fractures. In practice, the current guidelines use a T-score threshold at or below −2.5 at any skeletal site as one of the triggers for recommending surgery.
Getting the Diagnosis Right
The classic laboratory finding is elevated blood calcium alongside an inappropriately high (or even high-normal) parathyroid hormone level. “Inappropriately high” is the key phrase. In a healthy person whose calcium is already elevated, the parathyroid glands should be suppressed and producing very little hormone. When they are not, primary hyperparathyroidism is the leading explanation.
One important diagnostic pitfall is a harmless inherited condition called familial hypocalciuric hypercalcemia, which can mimic primary hyperparathyroidism on basic blood work. The distinction matters because this genetic condition does not benefit from surgery. The standard way to tell them apart is to measure how much calcium the kidneys are clearing. A calculation called the calcium-to-creatinine clearance ratio helps: values below about 0.01 suggest the familial condition rather than true primary hyperparathyroidism.13The Journal of Clinical Endocrinology & Metabolism. Letter to the Editor: Distinguishing Typical Primary Hyperparathyroidism From Familial Hypocalciuric Hypercalcemia by Using an Index of Urinary Calcium However, there is overlap near that cutoff. One study found that 24-hour urine calcium excretion is more sensitive for catching primary hyperparathyroidism, while the clearance ratio is better at ruling in the familial condition.14Postgraduate Medical Journal. Urinary calcium indices in primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcaemia (FHH): which test performs best? In ambiguous cases, genetic testing can settle the question.
Normocalcemic Primary Hyperparathyroidism
A subset of patients has consistently elevated parathyroid hormone but normal calcium levels. This variant, called normocalcemic primary hyperparathyroidism, was only formally described in the early 2000s and remains somewhat controversial. It is not simply an early or mild form of the classic disease, though it can evolve into it. In one cohort study, 40 percent of these patients went on to develop hypercalcemia, new kidney stones, fractures, marked increases in urinary calcium, or significant bone loss during follow-up.15The Journal of Clinical Endocrinology & Metabolism. Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype Even at the time of diagnosis, more than half already had osteoporosis. The clinical message is that normal calcium does not mean nothing is happening; these patients still need monitoring and, in some cases, surgery.
When Surgery Is Recommended
Parathyroidectomy is the only cure. The most recent international guidelines, from the Fifth International Workshop, recommend surgery for all patients who meet any of the following criteria:
- Calcium elevation: serum calcium more than 1 mg/dL above the upper limit of normal.
- Bone involvement: a fracture detected on imaging, or bone density T-score at or below −2.5 at any site.
- Kidney involvement: kidney function below 60 mL/min, kidney stones or nephrocalcinosis on imaging, or elevated urinary calcium excretion.
- Age: younger than 50 years, even with no other criteria met.
The guidelines note that surgery is an option for all patients with confirmed primary hyperparathyroidism, with the agreement of both patient and physician and no medical contraindications, but these criteria identify those who stand to benefit most clearly.16Journal of Bone and Mineral Research. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop
Modern Surgical Approaches
Parathyroid surgery has evolved considerably. When the disease is caused by a single adenoma that has been localized on imaging, a focused, minimally invasive operation can be performed through a small incision. Several variations exist, including open minimally invasive, radio-guided, and video-assisted techniques. The video-assisted approach offers better cosmetic outcomes, improved visualization of the surgical field, and less postoperative pain compared with the traditional open approach.17PubMed Central. Minimally-invasive parathyroid surgery
Intraoperative parathyroid hormone monitoring has become a game-changer for focused surgery. Because parathyroid hormone has a very short half-life in the blood, a rapid assay during the operation can confirm that hormone levels have dropped adequately after the adenoma is removed. In one study comparing patients who had this monitoring with those who did not, the monitored group achieved a 100 percent cure rate. When hormone levels failed to drop sufficiently, surgeons immediately explored further and found additional overactive glands, including double adenomas and multigland hyperplasia that would otherwise have been missed.18PubMed. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy
Localizing the Problem Before Surgery
Finding the abnormal gland before the operation is essential for a focused approach. The traditional tools are ultrasound and sestamibi scanning, a nuclear medicine test that highlights overactive parathyroid tissue. Both are widely available but have significant limitations. A newer technique, four-dimensional computed tomography (4D-CT), adds time-based contrast enhancement to anatomical imaging and has shown markedly better performance. In one study, 4D-CT had a sensitivity of about 76 percent and accuracy of about 76 percent for localizing adenomas, compared with roughly 32 percent sensitivity for ultrasound and 26 percent for sestamibi when used alone.19Insights into Imaging. The role of 4DCT in the localization of parathyroid adenomas in primary hyperparathyroidism: a retrospective cohort study In recurrent or persistent disease after a prior operation, 4D-CT was similarly superior, correctly lateralizing the problem in about 77 percent of cases versus 39 percent for ultrasound and 46 percent for sestamibi.20PubMed. 4D-CT is Superior to Ultrasound and Sestamibi for Localizing Recurrent Parathyroid Disease In practice, many centers now use 4D-CT as a first-line or complementary study when ultrasound and sestamibi results are discordant or negative.
Recovery and Hungry Bone Syndrome
Most patients feel noticeably better within days to weeks after a successful parathyroidectomy. Calcium levels typically normalize quickly, and many people describe a lifting of the mental fog they did not fully realize they had. One complication to watch for, though, is hungry bone syndrome, a sharp drop in blood calcium after surgery as the skeleton, suddenly freed from excess hormone, rapidly reabsorbs calcium from the bloodstream. In a study of patients with primary hyperparathyroidism undergoing surgery, roughly 13 percent developed this syndrome. The patients most at risk were older, had higher preoperative calcium and parathyroid hormone levels, more elevated markers of bone turnover, and larger adenomas.21PubMed. Hungry bone syndrome: clinical and biochemical predictors of its occurrence after parathyroid surgery Management involves calcium and vitamin D supplementation, and the condition is temporary, but it can cause unpleasant symptoms like tingling and muscle cramps in the meantime.
Medical Alternatives When Surgery Is Not an Option
For patients who cannot or choose not to undergo surgery, a medication called cinacalcet offers a way to control the calcium. Cinacalcet works by making the calcium-sensing receptor on parathyroid cells more sensitive, essentially tricking the glands into behaving as if calcium levels are higher than they are, which dials back hormone secretion. It reliably lowers both calcium and parathyroid hormone levels, and there is evidence it improves cognitive function as well.22PubMed Central. Cinacalcet treatment of primary hyperparathyroidism It does not, however, cure the underlying disease or improve bone density the way surgery does. The evidence base for cinacalcet in primary hyperparathyroidism comes from a mix of randomized trials comparing it with placebo and observational studies.23PubMed Central. Cinacalcet and primary hyperparathyroidism: systematic review and meta regression It is generally considered a reasonable option for people who are poor surgical candidates or who have mild disease that does not meet surgical criteria.
Hereditary Forms
While the vast majority of primary hyperparathyroidism is sporadic, a meaningful minority is hereditary. The best-known genetic form occurs in the context of multiple endocrine neoplasia type 1, a syndrome caused by mutations in a tumor-suppressor gene. Primary hyperparathyroidism is typically the first sign of this syndrome, appearing in more than 90 percent of mutation carriers, often between the ages of 20 and 25.24PubMed Central. Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery? Other hereditary syndromes linked to primary hyperparathyroidism include mutations in the CDC73 gene, which are associated with a higher risk of parathyroid carcinoma, and familial isolated hyperparathyroidism, where the parathyroid disease occurs without other endocrine tumors.
Genetic testing in a single-center study of hereditary cases identified pathogenic or likely pathogenic variants in about 70 percent of patients tested, along with a number of previously unknown mutations.25PubMed. Clinical phenotypes and genetic screening in hereditary primary hyperparathyroidism: A single-center case series Suspicion should be particularly high when primary hyperparathyroidism appears before age 40, involves multigland disease, recurs after surgery, or when there is a family history of high calcium or related endocrine tumors. When a germline mutation is found, screening of family members becomes important.
Primary Hyperparathyroidism in Pregnancy
Pregnancy adds a layer of complexity because the condition is easy to miss. The nonspecific symptoms of hyperparathyroidism, nausea, fatigue, and muscle weakness, overlap substantially with normal pregnancy complaints.26PubMed. Impact of Perinatal Primary Hyperparathyroidism on Maternal and Fetal and Neonatal Outcomes: Retrospective Case Series Physiological changes in pregnancy also alter calcium handling, making blood results harder to interpret. When the condition goes unrecognized, the consequences can be serious. A large study found that pregnant women with hyperparathyroidism had roughly 70 percent higher odds of preterm delivery and cesarean section, about three times the odds of preeclampsia, and their infants were more likely to be growth restricted or to have congenital anomalies.27PubMed. Obstetrical and neonatal outcomes among pregnancies complicated by hyperparathyroidism When the diagnosis is made during pregnancy, parathyroidectomy in the second trimester is generally considered the safest approach for cases with significantly elevated calcium.
Parathyroid Carcinoma
The rarest cause of primary hyperparathyroidism is cancer of the parathyroid gland itself. Parathyroid carcinoma tends to announce itself more dramatically than an adenoma. Patients typically present with profoundly elevated calcium and parathyroid hormone levels and severe symptoms of hyperparathyroidism. During surgery, the tumor is often large, gray-white, and visibly invading surrounding tissue, quite different from the small, well-contained adenoma seen in typical cases.28PubMed. Parathyroid carcinoma The course of the disease is variable. More than half of patients experience persistent or recurrent disease from regional or distant spread. Complete surgical removal at the initial operation, ideally as a wide excision including the thyroid lobe on the same side, is the single most important factor for a good outcome.29PubMed Central. Parathyroid Carcinoma: A Clinical Case Report and Literature Review There is no reliably effective chemotherapy or radiation for this cancer, which makes that first surgery critically important. Suspicion for carcinoma should be high when calcium levels are extremely elevated, the parathyroid hormone is many times above normal, or a neck mass is palpable, none of which are typical for a benign adenoma.